171 related articles for article (PubMed ID: 6865998)
1. Activation of nitrosamines and other carcinogens by mouse-liver S9, mouse hepatocytes and in the host-mediated assay produces different mutagenic responses in Salmonella TA1535.
Kerklaan P; Bouter S; Mohn G
Mutat Res; 1983; 110(1):9-22. PubMed ID: 6865998
[TBL] [Abstract][Full Text] [Related]
2. The effect of mixed-function oxidase and amine oxidase inhibitors on the activation of dialkylnitrosamines and 1,2-dimethylhydrazine to bacterial mutagens in mice.
Kerklaan PR; Bouter S; Zijlstra JA; Mohn GR
J Cancer Res Clin Oncol; 1986; 111(3):196-202. PubMed ID: 3525573
[TBL] [Abstract][Full Text] [Related]
3. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide].
Loknitskaia NN; Rotenberg IuS; Fonshteĭn LM; Shuliakovskaia TS
Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722
[TBL] [Abstract][Full Text] [Related]
4. Studies on the efficiency of the Salmonella/rat hepatocyte assay for the detection of carcinogens as mutagens: activation of 1,2-dimethyl-hydrazine and procarbazine into bacterial mutagens.
Malaveille C; Brun G; Bartsch H
Carcinogenesis; 1983; 4(4):449-55. PubMed ID: 6340851
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
Rumruen K; Pool BL
Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the DNA-repair host-mediated assay. I. Induction of repairable DNA damage in E. coli cells recovered from liver, spleen, lungs, kidneys, and the blood stream of mice treated with methylating carcinogens.
Kerklaan PR; Bouter S; van Elburg PA; Mohn GR
Mutat Res; 1985; 148(1-2):1-12. PubMed ID: 3881659
[TBL] [Abstract][Full Text] [Related]
7. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
8. A sensitive hepatocyte-mediated assay for the metabolism of nitrosamines to mutagens for mammalian cells.
Jones CA; Huberman E
Cancer Res; 1980 Feb; 40(2):406-11. PubMed ID: 7188682
[TBL] [Abstract][Full Text] [Related]
9. [Study of the process of promutagen biotransformation by the Ames test. I. The role of conjugation with glutathione in the modification of the mutagenic activity of nitrosomorpholine, diethylnitrosamine and cyclophosphamide].
Fonshteĭn LM; Loknitskaia NN; Rotenberg IuS
Genetika; 1985 Nov; 21(11):1821-7. PubMed ID: 3908219
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity testing with the Salmonella/hepatocyte and the Salmonella/microsome assays. A comparative study with some known genotoxic compounds.
Bos RP; Neis JM; van Gemert PJ; Henderson PT
Mutat Res; 1983 Nov; 124(2):103-12. PubMed ID: 6358883
[TBL] [Abstract][Full Text] [Related]
11. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting metabolism and mutagenicity of dimethylnitrosamine and diethylnitrosamine.
Frantz CN; Malling HV
Cancer Res; 1975 Sep; 35(9):2307-14. PubMed ID: 1097107
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity of some dialkylnitrosamines, cyclic nitrosamines and N,N-diethanolnitrosamine in Salmonella typhimurium with rat and rabbit nasal, lung and liver S9 homogenates.
Dahl AR
Mutat Res; 1985 Dec; 158(3):141-7. PubMed ID: 3908927
[TBL] [Abstract][Full Text] [Related]
14. Effect of dietary protein concentration on yield of mutagenic metabolites from 1,2-dimethylhydrazine in mice.
Kari FW; Johnston JB; Truex CR; Visek WJ
Cancer Res; 1983 Aug; 43(8):3674-9. PubMed ID: 6344989
[TBL] [Abstract][Full Text] [Related]
15. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
Negishi T; Hayatsu H
Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
[TBL] [Abstract][Full Text] [Related]
16. Comparison of co-cultivation of V79 cells with rat hepatocytes and rat H4IIE hepatoma cells for studying nitrosamine-induced hprt gene mutations.
Swedmark S; Romert L; Beije B; Diaz-Pohl C; Bäckbro A; Jenssen D
Mutagenesis; 1994 Jul; 9(4):281-7. PubMed ID: 7968567
[TBL] [Abstract][Full Text] [Related]
17. Activation of the colon carcinogen 1,2-dimethylhydrazine in a rat colon cell-mediated mutagenesis assay.
Oravec CT; Jones CA; Huberman E
Cancer Res; 1986 Oct; 46(10):5068-71. PubMed ID: 3756864
[TBL] [Abstract][Full Text] [Related]
18. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
19. Species specificity in the metabolism of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine to mutagens by isolated rat and hamster hepatocytes.
Mangino MM; Hollenberg PF; Scarpelli DG
Cancer Res; 1987 Sep; 47(18):4776-81. PubMed ID: 3113724
[TBL] [Abstract][Full Text] [Related]
20. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
